<DOC>
	<DOCNO>NCT00112749</DOCNO>
	<brief_summary>RATIONALE : Infliximab may help improve energy level patient undergone treatment breast cancer . PURPOSE : This phase II trial study well infliximab work treat cancer-related fatigue postmenopausal woman undergone treatment stage 0 , stage I , stage II breast cancer .</brief_summary>
	<brief_title>Infliximab Treating Cancer-Related Fatigue Postmenopausal Women Who Have Undergone Treatment Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine association body 's immune system energy , sleep , mood , symptom postmenopausal woman undergone treatment stage 0-II breast cancer . - Determine whether treatment infliximab affect energy immune function patient . OUTLINE : Patients receive infliximab IV 2 hour . Patients complete diary twice daily 14 day 14 day infliximab administration ass fatigue symptom , include mood , pain , sleep . After completion study treatment , patient follow 2 week monthly 3 month . PROJECTED ACCRUAL : A total 10 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Women report elevate fatigue follow cancer diagnosis treatment Women medical condition may affect immune system associate baseline fatigue syndrome , and/or use medication affect immune system fatigue . Women major affective disorder sleep pain disorder . Presence medical condition may subject undue risk experimental procedure . Chronic recur infection , symptom chronic heart failure , demyelinate disorder , take immunosuppressive medication . Neoplastic disease primary breast cancer Compromised cardiovascular function Insulindependent diabetes Neurological disorder Peripheral neuropathy Pregnancy Use psychotropic medication within 2 week screen Abnormal screen laboratory finding ( i.e. , creatinine &gt; 1.4mg % ; anemia ; abnormal thyroid hormone ; hematuria ; elevate liver function test , low protein albumin ; fast glucose &gt; 120mg % ; elevate FTI TSH ; positive TB screening , HIV screen hepatitis C ) . Smokers</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>breast cancer situ</keyword>
	<keyword>fatigue</keyword>
</DOC>